ICTS center launches program for minorities in research
A center in the Institute of Clinical and Translational Sciences received a grant establishing the School of Medicine as a coordinating center for the Short-Term Research Experience Program to Unlock Potential. STEP-UP is a National Institutes of Health (NIH) program to introduce scholars underrepresented in medicine to medical research.
Emergency communication test Sept. 20
Washington University Emergency Management plans to test its emergency communication system at 10 a.m. Tuesday, Sept. 20.
Rogers selected as scholar in emerging leadership program
Cynthia E. Rogers, MD, the Blanche F. Ittleson Professor of Psychiatry at the School of Medicine, has been named an Emerging Leader in Health and Medicine Scholar by the National Academy of Medicine.
Women’s Society seeks student proposals for funding
The Women’s Society of Washington University funding committee invites undergraduate students to submit funding requests for student-led projects. The deadline is Oct. 19.
Emenecker wins prize for innovation in biomedical science
Ryan Emenecker, a postdoctoral researcher at Washington University School of Medicine, has won the 2022 Regeneron Prize for Creative Innovation.
Sullivan receives Rising Star Award
Matt Sullivan, the university’s assistant director of disability resources, has received the Rising Star Award from the Coalition for Disability Access in Health Sciences Education.
World’s first nasal COVID-19 vaccine approved in India; based on Washington University technology
The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.
Drug combo therapy in mice blocks drug resistance, halts tumor growth
An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.
View More Stories